Skip to main content
Clinical Trials/NCT06338527
NCT06338527
Not yet recruiting
Not Applicable

Effects of Aromatherapy on Sleep Quality and Anxiety in Patients Undergoing Chemotherapy for Breast Cancer

Weifang Medical University1 site in 1 country90 target enrollmentMarch 26, 2024

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Sleep Quality
Sponsor
Weifang Medical University
Enrollment
90
Locations
1
Primary Endpoint
Sleep quality
Status
Not yet recruiting
Last Updated
2 years ago

Overview

Brief Summary

The objective of this study was to investigate the effects of aromatherapy on sleep quality and anxiety in patients undergoing chemotherapy for breast cancer.

Registry
clinicaltrials.gov
Start Date
March 26, 2024
End Date
June 15, 2024
Last Updated
2 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Sponsor
Weifang Medical University
Responsible Party
Principal Investigator
Principal Investigator

Jiang Liu

Research investigator

Weifang Medical University

Eligibility Criteria

Inclusion Criteria

  • patients diagnosed with breast cancer and receiving chemotherapy; 2) suffering from sleep disorders or PSQI score greater than 5; 3) not using medications such as antidepressants and hypnotics that may affect the observation results; 4) age older than 18 years and volunteered to participate in this study.

Exclusion Criteria

  • Asthma or severe respiratory disease; 2) Allergy to lavender; 3) Cognitive or communication disorders; 4) Breast cancer combined with severe organ dysfunction.

Outcomes

Primary Outcomes

Sleep quality

Time Frame: The sleep quality of the patients was assessed at 8 a.m. for one week.

The Pittsburgh Sleep Quality Index (PSQI) was used to assess the sleeping quality of the patients. The total score of PSQI ranged from 0-21, with higher scores indicating poor sleep quality.

Anxiety

Time Frame: The anxiety level of the patients was assessed at 8 a.m. for one week.

Beck Anxiety Inventory (BAI) was used to assess the anxiety level of the patients. The scale consists of 21 entries with a total score ranging from 0 to 63, with higher total scores being associated with more severe levels of anxiety.

Study Sites (1)

Loading locations...

Similar Trials